Skip to main content
SpringerLink
Log in

Lower Genitourinary Tract

  • Chapter
Clinical Nuclear Medicine

  • 2559 Accesses

Abstract

Conventional radionuclide techniques have, for many years, played a role in evaluating vesico-ureteral reflux and suspected testicular torsion. More recently, the advent of prostate immunoscintigraphy, positron emission tomography (PET) and PET/computed tomography (CT) has broadened nuclear medicine’s role to the area of oncologic diagnosis, as well. This chapter will first discuss the older standard techniques and follow with the oncologic applications in both the male and female genitourinary tract

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albers P, Bender H, Yilmaz H, et al. (1999) Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology 53:808–811

    Article  PubMed  CAS  Google Scholar 

  • Belhocine T, de Barsy C, Hustinx R, et al. (2002) Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29:1132–1139

    Article  PubMed  CAS  Google Scholar 

  • Bokemeyer C, Kollmannsberger C, Oechsle K, et al. (2002) Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET. Br J Cancer 86:506–511

    Article  PubMed  CAS  Google Scholar 

  • Bower M, Newlands ES, Holden L, et al. (1997) EMA/CO for high-risk gestational trophoblastic tumours: results from a cohort of 272 patients. J Clin Oncol 15:2636–2643

    PubMed  CAS  Google Scholar 

  • Boyle P, Leon ME, Maisonneuve P, Autier P (2003) Cancer control in women. Update 2003. Int J Gynecol Obstet 83 Suppl 1:179–202

    Article  Google Scholar 

  • Chang TC, Law KS, Hong JH, et al. (2004) Positron emission tomography for unexplained serum SCC-Ag elevation in cervical cancer patients —a phase II study. Cancer 101:164–171

    Article  PubMed  Google Scholar 

  • Chang TC, Yen TC, Ma SY, et al. (2006) 18F-fluoro-D-deoxyglucose positron emission tomography of trophoblastic tumor: a pilot study. Eur J Nucl Med Mol Imaging, doi: 10.1007/ S00259-005-1873-1

    Google Scholar 

  • Chao A, Chang YC, Hsueh S, et al. (2006) F-18 fluorodeoxyglucose positron emission tomography in the management of endometrial cancer. Eur J Nucl Med Mol Imaging 33:36–44

    Article  PubMed  Google Scholar 

  • Chou HH, Chang TC, Yen TC, et al. (2006) Low value of 2-fluoro-2-deoxy-d-glucose positron emission tomography in primary staging of early-stage cervical cancer prior to radical hysterectomy. J Clin Oncol 24:123–128

    Article  PubMed  Google Scholar 

  • Cohn DE, Dehdashti F, Gibb RK, et al. (2002) Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85:179–184

    Article  PubMed  Google Scholar 

  • Conway JJ, King LR, Belman AB, et al. (1972) Detection ofvesicoureteral reflux with radionuclide cystography. Am J Roentgenol 115:720

    CAS  Google Scholar 

  • Cremerius U, Wildberger JE, Borchers H, et al. (1999) Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?-Results of a study in 50 patients. Urology 54:900–904

    Article  PubMed  CAS  Google Scholar 

  • de Jong IJ, Pruim J, Elsinga PH, et al. (2003a) 1 lC-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 44:32–38

    Article  PubMed  Google Scholar 

  • de Jong IJ, Pruim J, Elsinga PH, et al. (2003b) Preoperative staging of pelvic lymph nodes in prostate cancer by 1 lC-choline PET. J Nucl Med 44:331–335

    PubMed  Google Scholar 

  • DeGrado TR, Wang S, Holden JE, et al. (2000) Synthesis and preliminary evaluation of (18)F-labeled 4-thiapalmitate as a PET tracer of myocardial fatty acid oxidation. Nucl Med Biol 27:221–231

    Article  PubMed  CAS  Google Scholar 

  • Dose J, Bohuslavizki K, Huneke B, et al. (2000) Detection of intramural choriocarcinoma of the uterus with 18F-FDG-PET. A case report. Clin Positron Imaging 3:37–40

    Article  PubMed  Google Scholar 

  • Dotters DJ (2000) Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 182:1328–1334

    Article  PubMed  CAS  Google Scholar 

  • Drieskens O, Oyen R, Van Poppel H, et al. (2005) FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 32:1412–1417

    Article  PubMed  CAS  Google Scholar 

  • Duk JM, Aalders JG, Fleuren GJ, de Bruijn HW (1986) CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 155:1097–1102

    PubMed  CAS  Google Scholar 

  • Farsad M, Schiavina R, Castellucci P, et al. (2005) Detection and localization of prostate cancer: correlation of HC-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46:1642–1649

    PubMed  CAS  Google Scholar 

  • Feltmate CM, Genest DR, Wise L, et al. (2001) Placental site trophoblastic tumour: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol 82: 415–419

    Article  PubMed  CAS  Google Scholar 

  • Fenchel S, Grab D, Nuessle K, et al. (2002) Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 223:780–788

    Article  PubMed  Google Scholar 

  • Freeman LM, Krynyckyi BR, Li Y, et al. (2002) The role of 111In Capromab Pendetide (ProstascintR) immunoscintigraphy in the management of prostate cancer. Q J Nucl Med 46: 131–137

    PubMed  CAS  Google Scholar 

  • Fricke E, Machtens S, Hofmann M, et al. (2003) Positron emission tomography with HC-acetateand 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging 30:607–611

    Article  PubMed  CAS  Google Scholar 

  • Grab D, Flock F, Stohr I, et al. (2000) Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positive emission tomography. Gynecol Oncol 77:454–459

    Article  PubMed  CAS  Google Scholar 

  • Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745–3749

    PubMed  CAS  Google Scholar 

  • Grigsby PW, Mutch DG, Rader J, et al. (2005) Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys 61:3441–3449

    Article  Google Scholar 

  • Hain SF, O’Doherty MJ, Timothy AR, et al. (2000) Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83:863–869

    Article  PubMed  CAS  Google Scholar 

  • Hara T, Kosaka N, Kishi H (1998) PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39:990–995

    PubMed  CAS  Google Scholar 

  • Harisinghani MG, Barentsz J, Hahn PF, et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499

    Article  PubMed  Google Scholar 

  • Heaps JM, Fu YS, Montz FJ, et al. (1990) Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38:309–314

    Article  PubMed  CAS  Google Scholar 

  • Hebart H, Erley C, Kaskas B, et al. (1996) Positron emission tomography helps to diagnose tumour emboli and residual disease in choriocarcinoma. Ann Oncol 7:416–418

    PubMed  CAS  Google Scholar 

  • Hong JH, Tsai CS, Lai CH, et al. (2004) Recurrent squamous cell carcinoma of cervix following definitive radiotherapy. Int J Radiat Oncol Biol Phys 60:249–257

    Article  PubMed  Google Scholar 

  • Horowitz NS, Dehdashti F, Herzog TJ, et al. (2004) Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 101:164–171

    Google Scholar 

  • Hubner KF, McDonald TW, Niethammer JG, et al. (1993) Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Gynecol Oncol 51:197–204

    Article  PubMed  CAS  Google Scholar 

  • Kahn D, Williams RD, Manyak MJ, et al. (1998) 111In Capromab Pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. J Urol 159:2041–2047

    Article  PubMed  CAS  Google Scholar 

  • Kang DE, White RL, Jr, Zuger JH, et al. (2004) Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 171:1806–1809

    Article  PubMed  Google Scholar 

  • Kao MS (2004) Management of recurrent endometrial cancer. Chang Gung Med J 27:639–645

    PubMed  Google Scholar 

  • Kato T, Tsukamoto E, Kuge Y, et al. (2002) Accumulation of [11C] acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med Mol Imaging 29:1492–1495

    Article  PubMed  CAS  Google Scholar 

  • Kosuda S, Kison PV, Greenough R, et al. (1997) Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med Mol Imaging 24:615–620

    CAS  Google Scholar 

  • Kotzerke J, Volkmer BG, Neumaier B, et al. (2002) Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 29:1380–1384

    Article  PubMed  CAS  Google Scholar 

  • Kroon BK, Horenblas S, Meinhardt W, et al. (2005) Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 47:601–606

    Article  PubMed  Google Scholar 

  • Kurdziel KA, Figg WD, Carrasquillo JA, et al. (2003) Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11 CO, and 15O-water for monitoring androgen independent prostate cancer. Mol Imaging Biol 5:86–93

    Article  PubMed  Google Scholar 

  • Kurokawa T, Yoshida Y, Kawahara K, et al. (2002) Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range. Ann Nucl Med 6:491–493

    Article  Google Scholar 

  • Lai CH (2004) Management of recurrent cervical cancer. Chang Gung Med J 72:711–719

    Google Scholar 

  • Lai CH, Huang KG, See LC, et al. (2004) Restaging of recurrent cervical cancer with dual-phase positron emission tomography. Cancer 100:544–552

    Article  PubMed  Google Scholar 

  • Lamb HM, Faulds D (1998) Capromab pendetide. A review of its use as an imaging agent in prostate cancer. Drugs Aging 12:293–304

    Article  PubMed  CAS  Google Scholar 

  • Lamoreaux WT, Grigsby PW, Dehdashti F, et al. (2005) FDG-PET evaluation of vaginal cancer. Int J Radiat Oncol Biol Phys 62:733–737

    Article  PubMed  Google Scholar 

  • Lerman H, Metser U, Grisaru D, et al. (2004) Normal and abnormal 18F-FDG endometrial and ovarian uptake pre-and postmenopausal patients: assessment by PET/CT. J Nucl Med 45:266–271

    PubMed  Google Scholar 

  • Majhail NS, Urbain J-L, Albani JM, et al. (2003) F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 21:3995–4000

    Article  PubMed  Google Scholar 

  • Manfredi R, Mirk P, Maresca G, et al. (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378

    Article  PubMed  Google Scholar 

  • Matthies A, Ezziddin S, Ulrich E-M, et al. (2004) Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT. Eur J Nucl Med Mol Imaging 31:797

    Article  PubMed  Google Scholar 

  • Morris MJ, Akhurst T, Osman I, et al. (2002) Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 59:913–918

    Article  PubMed  Google Scholar 

  • Nakahara T, Fujii H, Ide M, et al. (2001) F-18 FDG uptake in endometrial cancer. Clin Nucl Med 26:82–83

    Article  PubMed  CAS  Google Scholar 

  • Newlands ES, Bower M, Holden L, et al. (1998) Management of resistant gestational trophoblastic tumours. J Reprod Med 43:111–118

    PubMed  CAS  Google Scholar 

  • Nunez R, Macapinlac HA, Yeung HWD, et al. (2002) Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. J Nucl Med 43:46–55

    PubMed  Google Scholar 

  • Oyama N, Akino H, Suzuki Y, et al. (1999) The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol 29:623–629

    Article  PubMed  CAS  Google Scholar 

  • Oyama N, Akino H, Suzuki Y, et al. (2001) FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. Nucl Med Commun 22:963–969

    Article  PubMed  CAS  Google Scholar 

  • Oyama N, Akino H, Kanamaru H, et al. (2002) 11C-acetate PET imaging of prostate cancer. J Nucl Med 43:181–186

    PubMed  CAS  Google Scholar 

  • OyamaN, Miller TR, Dehdashti F, et al. (2003) 1 lC-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 44:549–555

    Google Scholar 

  • Oyama N, Ponde DE, Dence C, et al. (2004) Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation. J Nucl Med 45:519–525

    PubMed  CAS  Google Scholar 

  • Picchio M, Messa C, Landoni C, et al. (2003) Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 169:1337–1340

    Article  PubMed  CAS  Google Scholar 

  • Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B (2005) Role of CT and MR imaging in predicting opt imalcyto reduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96:301–306

    Article  PubMed  Google Scholar 

  • Ramdave S, Thomas GW, Berlangieri SU, et al. (2001) Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 166:825–830

    Article  PubMed  CAS  Google Scholar 

  • Reinhardt MJ, Ehitt-Braun C, Vogelgesang D, et al. (2001) Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG-PET. Radiology 218:776–782

    PubMed  CAS  Google Scholar 

  • Rieber A, Nussle K, Stohr I, et al. (2001) Preoperative diagnosis of ovarian tumors with magnetic resonance imaging: Comparison with transvaginal sonography, positive emission tomog-raphy and histologic findings. Am J Roentgenol 177:123–129

    CAS  Google Scholar 

  • Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17:41–45

    PubMed  CAS  Google Scholar 

  • Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH (2003) Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 44: 347–352

    PubMed  Google Scholar 

  • Safaei A, Figlin R, Hoh CK, et al. (2002) The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 57:56–62

    PubMed  CAS  Google Scholar 

  • Saga T, Higashi T, Ishimori T, et al. (2003) Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 17:197–203

    PubMed  Google Scholar 

  • Saitoh H, Yoshida KL, Uchijima Y, et al. (1990) Two different lymph node metastatic patterns of a prostate cancer. Cancer 65:1843–1845

    Article  PubMed  CAS  Google Scholar 

  • Salminen E, Hogg A, Binns D, et al. (2002) Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Acta Oncol 41:425–429

    Article  PubMed  Google Scholar 

  • Scher B, Seitz M, Reiser M, et al. (2005) 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 46:1460–1465

    PubMed  Google Scholar 

  • Schmid DT, John H, Zweifel R, et al. (2005) Fluorocholine PET/ CT in patients with prostate cancer: initial experience. Radiology 235:623–628

    Article  PubMed  Google Scholar 

  • Sedlis A, Homesley H, Bundy BN, et al. (1987) Positive groin lymph nodes in superficial squamous cell vulvar cancer. Am J Obstet Gynecol 156:1159–1164

    PubMed  CAS  Google Scholar 

  • Shreve P, Chiao PC, Humes HD, et al. (1995) Carbon-11-acetate PET imaging in renal disease. J Nucl Med 36:1595–1601

    PubMed  CAS  Google Scholar 

  • Sironi S, Picchio M, Mangili G, et al. (2003) [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumour: preliminary results in three patients. Gynecol Oncol 91:226–230

    Article  PubMed  CAS  Google Scholar 

  • Sironi S, Messa C, Mangili G, et al. (2004) Integrated FDG PET/ CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 233:433–440

    Article  PubMed  Google Scholar 

  • Sugawara Y, Zasadny KR, Grossman HB, et al. (1999) Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology 211:249–256

    PubMed  CAS  Google Scholar 

  • Sutinen E, Nurmi M, Roivainen A, et al. (2004) Kinetics of [(1l)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 31:317–324

    Article  PubMed  CAS  Google Scholar 

  • Torizuka T, Kanno T, Futatsubashi M, et al. (2003) Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J Nucl Med 44:1051–1056

    PubMed  CAS  Google Scholar 

  • Truenbach J, Pereira PL, Huppert PE, et al. (1997) Primary choriocarcinoma of the pulmonary artery mimicking pulmonary embolism. Br J Radiol 70:843–845

    Google Scholar 

  • Tsai CS, Chang TC, Lai CH, et al. (2004) Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 58:1506–1512

    Article  PubMed  Google Scholar 

  • Waggoner SE (2003) Cervical cancer. Lancet 361:2217–2225

    Article  PubMed  Google Scholar 

  • Wawroschek F, Vogt H, Wengenmair H, et al. (2003) Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70:303–310

    Article  PubMed  Google Scholar 

  • Yen TC, Ng KK, Ma SY, et al. (2003) Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J Clin Oncol 21:3651–2658

    Article  PubMed  Google Scholar 

  • Yen TC, See LC, Ma SY, et al. (2004) Defining priority of utilizing 18F-fluoro-D-deoxyglucose positron emission tomography for recurrent cervical cancer. J Nucl Med 45:1632–1639

    PubMed  Google Scholar 

  • Yoshida Y, Kurokawa T, Kawahara K, et al. (2004) Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. Am J Roentgenol 182:227–233

    Google Scholar 

  • Zhuang H, Yamamoto AJ, Ghesani N, et al. (2001) Detection of choriocarcinoma in the lung by FDG positron emission tomography. Clin Nucl Med 26:723

    Article  PubMed  CAS  Google Scholar 

  • Zuckier LS, Finklestein M, Kreutzer ER, et al. (1990) Technetium-99m antimony sulphide colloid lymphoscintigraphy of the prostate by direct transrectal injection. Nucl Med Commun 11:589–596

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Chang Gung Medical Center, 199, Tung Hwa North Road, Taipei, Taiwan

    Tzu-Chen Yen MD

  2. Department of Urology, Chang Gung Medical Center, 199 Tung Hwa North Road, Taipei, Taiwan

    Cheng-Keng Chuang MD, PhD

  3. Department of Obstetrics and Gynecology Chang Gung Memorial Hospital, Linkou Medical Center, 5 Fu-Shin St. Kueishan, Taoyuan, 333, Taiwan

    Chyong-Huey Lai MD

Authors
  1. Tzu-Chen Yen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheng-Keng Chuang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chyong-Huey Lai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Straße 15, D-53127, Bonn, Germany

    Hans-Jürgen Biersack M.D. (Professor and Chairman) (Professor and Chairman)

  2. Nuclear Medicine and Radiology, Albert Einstein College of Medicine Director, Dept. of Nuclear Medicine Montefiore Medical Centre/Moses Division, 111 East 210th Street, Bronx, NY, 10467, USA

    Leonard M. Freeman M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Yen, TC., Chuang, CK., Lai, CH. (2007). Lower Genitourinary Tract. In: Biersack, HJ., Freeman, L.M. (eds) Clinical Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-28026-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-28026-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28025-5

  • Online ISBN: 978-3-540-28026-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation